The effect of Sofoofe Banafshe on migraines
Phase 2
- Conditions
- migraine.Use additional external cause code (Chapter XX), if desired, to identify drug, if drug-induced.
- Registration Number
- IRCT2016110830776N1
- Lead Sponsor
- The Research Center of Neurology Diseases, Kerman University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 86
Inclusion Criteria
confirmed the diagnosis of migraine according to the criteria of IHS; 15-45 age range; patients' awareness of their disease, no pregnancy or lactation, without any other chronic diseases (heart, thyroid, hepatic, renal, neurologic, hypertension, diabetes, depression, etc.), experiencing at least four migraine attacks per month in the past few months
Exclusion criteria: dislike continuing cooperation, deciding for pregnancy or having a positive pregnancy test, experiencing non-migraine headaches; non-compliance with prescribed medication
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The number of migraine attacks per week. Timepoint: Two weeks and one month after intervention. Method of measurement: Self made questionnaire.;Severity of headache. Timepoint: Two weeks and one month after intervention. Method of measurement: VAS.;Freqency of headaches. Timepoint: Two weeks and one month after intervention. Method of measurement: Self made questionnaire.
- Secondary Outcome Measures
Name Time Method Quality of life. Timepoint: Two weeks and one month after intervention. Method of measurement: SF36.